Kodiak Sciences Inc. (KOD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Viewpoint - Kodiak has made significant progress since its last R&D Day in July, with positive developments occurring and challenges being avoided, leading to an optimistic outlook for 2026 and 2027 [1]. Group 1 - Kodiak's CEO, Victor Perlroth, expressed enthusiasm about the company's advancements and the exciting future ahead [1]. - The company aims to efficiently present a substantial amount of information regarding its operations and developments [2].